Evidence map›Paper›PMID 38487501›Full record

ReviewHealth data science2021

Active Vaccine Safety Surveillance: Global Trends and Challenges in China.

Zhike Liu, Ruogu Meng, Yu Yang, Keli Li, Zundong Yin, Jingtian Ren, Chuanyong Shen, Zijian Feng, Siyan Zhan

Open access · diamondAbstract readReview
In one paragraph

Review in Health data science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Zhike LiuDepartment of Epidemiology and Biostatistics, Peking University Health Science Center, Beijing, China.ORCID https://orcid.org/0000-0002-3232-8196
Ruogu MengNational Institute of Health Data Science, Peking University, Beijing, China.
Yu YangNational Institute of Health Data Science, Peking University, Beijing, China.ORCID https://orcid.org/0000-0002-5611-8951
Keli LiNational Immunization Programme, Chinese Center for Disease Control and Prevention, Beijing, China.
Zundong YinNational Immunization Programme, Chinese Center for Disease Control and Prevention, Beijing, China.
Jingtian RenCenter for Drug Reevaluation, National Medical Products Administration, BeijingChina.
Chuanyong ShenCenter for Drug Reevaluation, National Medical Products Administration, BeijingChina.
Zijian FengNational Immunization Programme, Chinese Center for Disease Control and Prevention, Beijing, China.
Siyan ZhanDepartment of Epidemiology and Biostatistics, Peking University Health Science Center, Beijing, China.ORCID https://orcid.org/0000-0001-7252-5349
Peking University · CNChinese Center For Disease Control and Prevention · CNNational Medical Products Administration · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38487501
PMCPMC10880162
OpenAlexW3171572498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.